1-236795383-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000254.3(MTR):​c.-321C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000433 in 1,403,430 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00090 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00038 ( 5 hom. )

Consequence

MTR
NM_000254.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0770

Publications

1 publications found
Variant links:
Genes affected
MTR (HGNC:7468): (5-methyltetrahydrofolate-homocysteine methyltransferase) This gene encodes the 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
MTR Gene-Disease associations (from GenCC):
  • methylcobalamin deficiency type cblG
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 1-236795383-C-G is Benign according to our data. Variant chr1-236795383-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 296536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000899 (137/152354) while in subpopulation EAS AF = 0.0166 (86/5172). AF 95% confidence interval is 0.0138. There are 0 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTRNM_000254.3 linkc.-321C>G 5_prime_UTR_variant Exon 1 of 33 ENST00000366577.10 NP_000245.2 Q99707-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTRENST00000366577.10 linkc.-321C>G 5_prime_UTR_variant Exon 1 of 33 1 NM_000254.3 ENSP00000355536.5 Q99707-1

Frequencies

GnomAD3 genomes
AF:
0.000900
AC:
137
AN:
152236
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000699
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0168
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00195
AC:
252
AN:
129128
AF XY:
0.00168
show subpopulations
Gnomad AFR exome
AF:
0.00114
Gnomad AMR exome
AF:
0.0000414
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0228
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000203
Gnomad OTH exome
AF:
0.000760
GnomAD4 exome
AF:
0.000376
AC:
470
AN:
1251076
Hom.:
5
Cov.:
30
AF XY:
0.000350
AC XY:
215
AN XY:
614492
show subpopulations
African (AFR)
AF:
0.000387
AC:
11
AN:
28458
American (AMR)
AF:
0.0000318
AC:
1
AN:
31414
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20842
East Asian (EAS)
AF:
0.0139
AC:
326
AN:
23536
South Asian (SAS)
AF:
0.0000650
AC:
5
AN:
76938
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
20840
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5058
European-Non Finnish (NFE)
AF:
0.00000603
AC:
6
AN:
994330
Other (OTH)
AF:
0.00244
AC:
121
AN:
49660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000899
AC:
137
AN:
152354
Hom.:
0
Cov.:
33
AF XY:
0.000819
AC XY:
61
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000697
AC:
29
AN:
41596
American (AMR)
AF:
0.000653
AC:
10
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0166
AC:
86
AN:
5172
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000427
Hom.:
1
Bravo
AF:
0.00100
Asia WGS
AF:
0.0130
AC:
45
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Disorders of Intracellular Cobalamin Metabolism Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:1
May 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.5
DANN
Benign
0.62
PhyloP100
0.077
PromoterAI
-0.085
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs187186973; hg19: chr1-236958683; API